ABEO
Abeona Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.00
+1.18%Margins
Gross margin
56.6%
EBITDA margin
-279.9%
EBIT margin
-327.6%
Net margin
-246.4%
FCF margin
-319.5%
-49.1%
Return on equity
-35.0%
Return on assets
-56.5%
Return on invested capital
0.14x
Asset turnover
-$76.4M
Cash from operations
$2.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026